Q (sonnet): How many patients and samples are in the MSK-CHORD Study? ▶ get_study_guide { "study_id": "msk_chord_2024" } ◀ result # MSK-CHORD (MSK, Nature 2024) **Study ID:** `msk_chord_2024` ## Overview Targeted sequencing via MSK-IMPACT panels. Clinical annotations include some derived from natural language processing (denoted NLP). **Exactly five cancer types** (`CANCER_TYPE`, patients): Non-Small Cell Lung Cancer 7,809, Colorectal Cancer 5,543, Breast Cancer 5,368, Prostate Cancer 3,211, Pancreatic Cancer 3,109. There is **no melanoma** or any other cancer type; say so up front if asked, instead of substituting another type. **No therapy-response variable.** There is no RECIST, objective response, or best-response attribute or event. For treatment-outcome questions (e.g. immunotherapy response), say this first; the only proxies are `OS_MONTHS`/`OS_STATUS`, or NLP radiology progression events (`Diagnosis` events with `SUBTYPE = 'Progression'`, key `PROGRESSION` = Y/N/Indeterminate), in patients with `Treatment` events of the relevant `SUBTYPE` (e.g. `Immuno`: 3,341 patients). Hand off the comparison to cBioPortal group comparison / survival. **Nearly one sample per patient: 24,950 patients / 25,040 samples.** Only 90 patients have more than one sample, and all 90 have samples from two different cancer types (second primaries); only 26 have both a `Primary` and a `Metastasis` sample. There is no meaningful same-patient (paired) primary-vs-metastasis cohort. For "same patient" / paired questions, say this up front, then offer the **unpaired** comparison of all `Primary` vs `Metastasis` samples (`SAMPLE_TYPE`), labelled as unpaired. ```sql SELECT countIf(n > 1) AS multi_sample_patients, -- 90 countIf(has_p AND has_m) AS primary_and_met -- 26 FROM (SELECT patient_unique_id, count() AS n, has(groupArray(attribute_value), 'Primary') AS has_p, has(groupArray(attribute_value), 'Metastasis') AS has_m FROM clinical_data_derived WHERE cancer_study_identifier = 'msk_chord_2024' AND attribute_name = 'SAMPLE_TYPE' GROUP BY patient_unique_id); ``` ## Gene Panels This study uses multiple MSK-IMPACT panel versions: - **IMPACT341**: Earlier version, 341 genes - **IMPACT410**: 410 genes - **IMPACT468**: 468 genes - **IMPACT505**: Latest version, 505 genes **Important:** Different samples may have different gene coverage. Always use gene-specific denominators when calculating mutation frequencies. ## Clinical Attributes - Semantic Guide ### Cancer Classification | Attribute | Description | Values | |-----------|-------------|--------| | `CANCER_TYPE` | Broad cancer category | e.g., "Non-Small Cell Lung Cancer", "Breast Cancer" | | `CANCER_TYPE_DETAILED` | Specific subtype | e.g., "Lung Adenocarcinoma", "Invasive Ductal Carcinoma" | | `ONCOTREE_CODE` | OncoTree classification code | Standardized cancer type codes | ### Sample Information | Attribute | Description | Values | |-----------|-------------|--------| | `SAMPLE_TYPE` | Sample origin | Primary, Metastasis, Local Recurrence, Unknown | | `SAMPLE_CLASS` | Sample … (5439 more chars) ▶ clickhouse_run_select_query { "query": "SELECT count(DISTINCT patient_unique_id) AS n_patients, count(DISTINCT sample_unique_id) AS n_samples FROM clinical_data_derived WHERE cancer_study_identifier = 'msk_chord_2024'" } ◀ result {"rows":[{"n_patients":24950,"n_samples":25041}]} ▶ resolve_and_route { "studyIds": [ "msk_chord_2024" ] } ◀ result {"success":true,"message":"Found 1 study. Use the metadata to call the appropriate navigation tool(s).","data":{"totalCount":1,"studiesWithMetadata":[{"studyId":"msk_chord_2024","name":"MSK-CHORD (MSK, Nature 2024)","sampleCount":25040,"studyViewUrl":"https://www.cbioportal.org/study?id=msk_chord_2024","metadata":{"clinicalAttributeIds":["ADRENAL_GLANDS","BONE","CANCER_TYPE","CANCER_TYPE_DETAILED","CLINICAL_GROUP","CLINICAL_SUMMARY","CNS_BRAIN","CURRENT_AGE_DEID","DIAGNOSIS_DESCRIPTION","ETHNICITY","FRACTION_GENOME_ALTERED","GENDER","GENE_PANEL","GLEASON_FIRST_REPORTED","GLEASON_HIGHEST_REPORTED","GLEASON_SAMPLE_LEVEL","HER2","HISTORY_OF_PDL1","HR","ICD_O_HISTOLOGY_DESCRIPTION","INTRA_ABDOMINAL","LIVER","LUNG","LYMPH_NODES","METASTATIC_SITE","MSI_COMMENT","MSI_SCORE","MSI_TYPE","MUTATION_COUNT","NUM_ICDO_DX","ONCOTREE_CODE","OS_MONTHS","OS_STATUS","OTHER","PATHOLOGICAL_GROUP","PDL1_POSITIVE","PLEURA","PRIMARY_SITE","PRIOR_MED_TO_MSK","RACE","REPRODUCTIVE_ORGANS","SAMPLE_CLASS","SAMPLE_COUNT","SAMPLE_COVERAGE","SAMPLE_TYPE","SMOKING_PREDICTIONS_3_CLASSES","SOMATIC_STATUS","STAGE_HIGHEST_RECORDED","TMB_NONSYNONYMOUS","TUMOR_PURITY"],"molecularProfileIds":["msk_chord_2024_cna","msk_chord_2024_mutations","msk_chord_2024_structural_variants"],"availableComparisonTabs":["overlap","clinical","survival","alterations","mutations"]}}]}} ▶ navigate_to_study_view { "studyIds": [ "msk_chord_2024" ] } ◀ result {"success":true,"message":"Navigating to https://www.cbioportal.org/study/summary?id=msk_chord_2024","url":"https://www.cbioportal.org/study/summary?id=msk_chord_2024","data":{"studyIds":["msk_chord_2024"],"studies":[{"studyId":"msk_chord_2024","name":"MSK-CHORD (MSK, Nature 2024)","sampleCount":25040}],"tab":"summary","hasFilters":false,"hasPlotsConfig":false,"pageDescription":"Overview of all study data displayed as interactive charts summarizing available clinical and genomic data. Click within a chart to filter. Additional charts may be available in the Charts menu."}} ═ answer (success) **MSK-CHORD (MSK, Nature 2024)** - **Patients:** 24,950 - **Samples:** 25,040 (25,041 distinct sample IDs by direct query, consistent with reported total) This is a near 1:1 patient-to-sample cohort — only 90 patients contribute more than one sample (all representing second primary cancers of a different type), and just 26 have both a Primary and a Metastasis sample. [View MSK-CHORD Study Overview](https://www.cbioportal.org/study/summary?id=msk_chord_2024)